AquaBounty Technologies, Inc.

Report azionario NasdaqCM:AQB

Capitalizzazione di mercato: US$4.8m

AquaBounty Technologies Performance degli utili passati

Criteri Il passato verificati 0/6

AquaBounty Technologies ha registrato una crescita degli utili a un tasso medio annuo di 28.5%, mentre il settore Biotechs ha registrato utili in crescita a un tasso medio annuo di 36.2%. I ricavi sono stati in diminuzione a un tasso medio annuo di 39.4%.

Informazioni chiave

28.47%

Tasso di crescita degli utili

33.25%

Tasso di crescita dell'EPS

Biotechs Crescita del settore17.04%
Tasso di crescita dei ricavi-39.40%
Rendimento del capitale proprion/a
Margine netton/a
Ultimo aggiornamento sugli utili31 Mar 2026

Aggiornamenti sulle prestazioni recenti

Recent updates

Seeking Alpha • Aug 20

AquaBounty: Not Casting A Lure Yet

This land-based salmon producer is a unique take on aquaculture, but risks abound. The current market cap does not take into consideration the low production plans, even with a new facility under construction. The looming clouds on the horizon means I will dock my boat for until things clear. A Pass On Land Based Fish Farms AquaBounty (AQB) is a company developing dry land farms to raise and sell salmon to the market to take demand away from wild caught salmon. The hot words to consider is that these salmon are both genetically engineered and farm raised. Public image issues aside, other risks that have plagued the company are due to the lack of FDA approval (of farm sites) and harvest issues. This has prevented this aging company from seeing any significant development since the early 90s. AquaBounty August Investor Presentation Advantages of the AquaBounty platform, or the trademark AquAdvantage Salmon, are many-fold. Initially, the major benefits revolve around faster growth, reproduction cycles, and ease of harvest, all allowing for a reduction in salmon cost. This either allows AquaBounty to sell at market price for a significant profit, or attempt to steal major market share by offering the lowest prices. Residual effects revolve around the issues inherent in wild-caught fish: ecological impacts, transportation impact, catch risks, food-borne illness, or biomagnification. The current issue is that AquaBounty is still working out the kinks and is yet to produce a full-scale operational facility. However, the bet is that once equilibrium is found, the platform, or these farms and salmon, can be developed worldwide, and the market share looks to be significant. In particular, it seems that commercial usage looks quite favorably upon the genetically engineered salmon, and in time, retail consumers may swing around as well. Investors should feel quite confident in the ability to find customers, but uncertainty around the funding of aquaculture centers and the improvement of harvest yields will be an issue for the coming years. Just look at the small amount of revenues that have been found since initiating the process nearly 30 years ago. Koyfin Revenues are derived from two initial farms in Indiana and Prince Edward Island, Canada. However, these sites will only have a maximum yield of approximately 1,000 metric tons per year. This contrasts significantly with the over 160 million tons of salmon processed per year, in the US. The table below is a great way to realize the sheer size of the fishery market, and to begin understanding the benefits of taking a dent out of the amount of fish we obtain from the oceans. Because of this, AquaBounty’s story will remain not one plagued by demand issues, but rather supply constraints. To combat the lack of supply from their two initial production experiment sites, the company has recently begun construction of a larger 10,000 metric ton facility that will easily provide over 5x current harvest yields. NOAA Fisheries 2020 Report The main problem, as usual, is money. While the company has done well to raise millions at the peak of the recent bull market, current estimates for the price of the new facility will drain the coffer. Now the company is not looking to dilute but to issue bonds instead, partially tempering the hit to current shareholders. However, no funding has come for six quarters and the cash on hand is slowly falling away. As of the August earnings press release, management had the following comments: On the bond financing front, we have decided to slow the process down temporarily in order to evaluate the current economic forces that are driving both inflation and interest rates higher. Since our estimate for construction of the farm currently exceeds our previous range of $290 - $320 million, we will review all options for reducing cost, including potentially phasing the construction of the 10,000 metric ton farm with an initial production output level that would demonstrate our competitive advantage and ability to operate at commercial scale. Koyfin AquaBounty The Future As only uncertainty exists and current supply is only worth a few million per year, I will certainly be remaining on the sideline. However, I look to the success of their construction and will be following their developments. If you are interested in this story, I will offer some valuation points to consider. Based on prices provided by the 2020 NOAA Fisheries report (see above), the value per pound for Salmon is approximately $5/lb at commercial scale.
Seeking Alpha • Aug 09

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies press release (NASDAQ:AQB): Q2 GAAP EPS of -$0.08. Revenue of $1.07M (+365.2% Y/Y).
Seeking Alpha • Mar 15

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

AquaBounty is an aquaculture company that bioengineered an FDA-approved genetically modified fish (AquAdvantage salmon) that grows faster and requires less food. CEO Sylvia Wulf on challenging GMO misinformation. AquaBounty’s financials and what investors can expect moving forward in terms of capital raises and shareholder dilution.
Articolo di analisi • May 09

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Articolo di analisi • Feb 10

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Every investor in AquaBounty Technologies, Inc. ( NASDAQ:AQB ) should be aware of the most powerful shareholder groups...
Articolo di analisi • Dec 20

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Even if it's not a huge purchase, we think it was good to see that Richard Huber, the Independent Non-Executive...

Ripartizione dei ricavi e delle spese

Come AquaBounty Technologies guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storico di utili e ricavi

NasdaqCM:AQB Ricavi, spese e utili (USD Millions )
DataRicaviUtiliSpese G+ASpese di R&S
31 Mar 260-430
31 Dec 250-240
30 Sep 2502060
30 Jun 2501960
31 Mar 250-880
31 Dec 240-1190
30 Sep 24-2-31110
30 Jun 24-1-34120
31 Mar 240-10120
31 Dec 230-14131
30 Sep 232-25121
30 Jun 232-25121
31 Mar 233-24121
31 Dec 223-22111
30 Sep 223-22111
30 Jun 223-24112
31 Mar 222-23112
31 Dec 211-22102
30 Sep 211-22102
30 Jun 210-1992
31 Mar 210-1782
31 Dec 200-1672
30 Sep 200-1472
30 Jun 200-1372
31 Mar 200-1482
31 Dec 190-1372
30 Sep 190-1443
30 Jun 190-1453
31 Mar 190-1343
31 Dec 180-1243
30 Sep 180-1174
30 Jun 180-1074
31 Mar 180-1064
31 Dec 170-953
30 Sep 170-963
30 Jun 170-953
31 Mar 170-953
31 Dec 160-853
30 Sep 160-844
30 Jun 160-734
31 Mar 160-744
31 Dec 150-743
30 Sep 150-743

Guadagni di qualità: AQB al momento non è redditizia.

Margine di profitto in crescita: AQB al momento non è redditizia.

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: AQB non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 28.5% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di AQB nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: AQB non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Biotechs ( 54.5% ).

Rendimento del capitale proprio

ROE elevato: Le passività di AQB superano le sue attività, quindi è difficile calcolare il suo rendimento del capitale proprio.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/06/10 18:11
Prezzo dell'azione a fine giornata2026/06/10 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

AquaBounty Technologies, Inc. è coperta da 3 analisti. 0 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Frank BarlowKeefe, Bruyette, & Woods
Benjamin KlieveLake Street Capital Markets, LLC
Colin RuschOppenheimer & Co. Inc.